US tab

Analysis of the Repair of
Topoisomerase II DNA Damage

By: Eric Goldstein | Mentor: Dr. Mark Muller

References

[1] Hinz, J. M. (2010), Role of homologous recombination in DNA interstrand crosslink repair. Environmental and Molecular Mutagenesis, 51: 582–603. doi: 10.1002/em.20577.

[2] Yves Pommier, Elisabetta Leo, HongLiang Zhang, Christophe Marchand (2010), DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs. Chemistry & Biology 17, May 28, 2010.

[3] Gun E. Lee, Joo Hee Kim, Michael Taylor, and Mark T Muller (2010). DNA Methyltransferase 1 Associated Protein Is a Corepressor That Stimulates DNA Methylation Globally and Globally at Sites of DSB Repair. JBC, M110.148536.

[4] Zhang A, Lyu YL, Lin CP, Zhou N, Azarova AM, Wood LM, Liu LF. (2006). A protease pathway for the Repair of Topoisomerase II-DNA covalent complexes. JBC Volume 281, Number 47 pg 35997.

[5] Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JY, Wang JC, Liu LF. (2007). Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. JBC Vol 104 no 26.

[6] Pommier, Y, Leo E, Zhang H, Marchand C (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010 May 28;17(5):421-33.

[7] Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV. (2007). DNA Damage, Homology – Directed Repair and DNA Methylation. PLOSGenetics Vol 3, Issue 7 e110.

[8] Watson, Baker, Bell, Gann, Levine, Losick (2008). Molecular Biology of the Gene. Pearson Education. 6 ed.

[9] Junko Iijima, Zhihong Zeng, Shunichi Takeda, and Yoshihito Taniguchi (2010). RAP80 Acts Independently of BRCA1 in Repair of Topoisomerase II Poison-Induced DNA Damage. Cancer 70 (21).

[10] J R Spitzner, I K Chung, and M T Muller (1990). Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acid Res. 18(1): 1–11.

[11] Sandeep Burmaa, Benjamin P.C. Chena and David J. Chen (2006). Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair. Volume 5, Issues 9-10, 8 September 2006, Pages 1042-48.

[12] Emil Mladenova and George Iliakis (2011). Induction and repair of DNA double strand breaks: The increasing spectrum of non-homologous end joining pathways. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. doi:10.1016/j.mrfmmm.2011.02.005.

[13] J. Thomas Holthausena, Claire Wymana, and Roland Kanaar (2010). Regulation of DNA strand exchange in homologous recombination. DNA Repair. Volume 9, Issue 12, 10 December 2010, Pages 1264-1272

[14] Shrivastav M, De Haro LP, and Nickoloff JA (2008). Regulation of DNA double-strand break repair pathway choice. Cell Res 18, 134-147.

[15] Windhofer F, Krause S, Hader C, Schulz WA, and Florl AR (2008). Distinctive differences in DNA double-stranded break repair between normal urothelial and urothelial carcinoma cells. Mutat Res 638, 56 – 65.

[16] Kim CH, Park SJ, and Lee SH (2002). A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation. J Pharmacol Exp Ther 303, 753-59.

[17] Mao Zhiyong, Jiang Ying, Liu Xiang, Seluanov Andrei, and Gorbunova Vera (2009) DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 11, 683 –91.